RecruitingPhase 2NCT03810339

Toripalimab as Monotherapy in Participants With POLE or POLD-1 Mutated and Non-MSI-H Advanced Solid Tumors

Studying Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Sun Yat-sen University
Principal Investigator
Rui-hua Xu, MD, PhD
Sun Yat-sen University
Intervention
Toripalimab(drug)
Enrollment
35 enrolled
Eligibility
18-75 years · All sexes
Timeline
20192024

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03810339 on ClinicalTrials.gov

Other trials for Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia

Additional recruiting or active studies for the same condition.

See all trials for Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia

← Back to all trials